Virios Therapeutics, Inc.·4

Feb 28, 12:47 PM ET

Grosswald Ralph 4

4 · Virios Therapeutics, Inc. · Filed Feb 28, 2024

Insider Transaction Report

Form 4
Period: 2024-02-26
Grosswald Ralph
SVP OF OPERATIONS
Transactions
  • Award

    Stock Option (right to buy)

    2024-02-26+62,56862,568 total
    Exercise: $0.36Exp: 2034-02-26Common Stock (62,568 underlying)
Footnotes (1)
  • [F1]The stock option will vest 100% on February 26, 2025, one year following the grant date.

Documents

1 file
  • 4
    form4-02282024_050234.xmlPrimary